Signaling pathways in brain tumors and therapeutic interventions

S Li, C Wang, J Chen, Y Lan, W Zhang… - … and Targeted Therapy, 2023 - nature.com
Brain tumors, although rare, contribute to distinct mortality and morbidity at all ages.
Although there are few therapeutic options for brain tumors, enhanced biological …

Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology

K Hoang-Xuan, E Bessell, J Bromberg… - The Lancet …, 2015 - thelancet.com
The management of primary CNS lymphoma is one of the most controversial topics in neuro-
oncology because of the complexity of the disease and the very few controlled studies …

Targetable genetic features of primary testicular and primary central nervous system lymphomas

B Chapuy, MGM Roemer, C Stewart… - Blood, The Journal …, 2016 - ashpublications.org
Primary central nervous system lymphomas (PCNSLs) and primary testicular lymphomas
(PTLs) are extranodal large B-cell lymphomas (LBCLs) with inferior responses to current …

Circulating tumor DNA profiling for detection, risk stratification, and classification of brain lymphomas

JA Mutter, SK Alig, MS Esfahani, EM Lauer… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE Clinical outcomes of patients with CNS lymphomas (CNSLs) are remarkably
heterogeneous, yet identification of patients at high risk for treatment failure is challenging …

The genomic and transcriptional landscape of primary central nervous system lymphoma

J Radke, N Ishaque, R Koll, Z Gu, E Schumann… - Nature …, 2022 - nature.com
Primary lymphomas of the central nervous system (PCNSL) are mainly diffuse large B-cell
lymphomas (DLBCLs) confined to the central nervous system (CNS). Molecular drivers of …

Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept'iLOC study …

C Soussain, S Choquet, M Blonski, D Leclercq… - European journal of …, 2019 - Elsevier
Background Primary central nervous system lymphomas (PCNSLs) are mainly diffuse large
B-cell lymphomas (DLBCLs) of the non-germinal centre B-cell subtype, with unmet medical …

Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing

RD Morin, K Mungall, E Pleasance… - Blood, The Journal …, 2013 - ashpublications.org
Diffuse large B-cell lymphoma (DLBCL) is a genetically heterogeneous cancer composed of
at least 2 molecular subtypes that differ in gene expression and distribution of mutations …

The BET bromodomain inhibitor OTX015 affects pathogenetic pathways in preclinical B-cell tumor models and synergizes with targeted drugs

M Boi, E Gaudio, P Bonetti, I Kwee, E Bernasconi… - Clinical Cancer …, 2015 - AACR
Purpose: In cancer cells, the epigenome is often deregulated, and inhibition of the
bromodomain and extra-terminal (BET) family of bromodomain-containing proteins is a …

Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma

C Grommes, JL Rubenstein, LM DeAngelis… - Neuro …, 2019 - academic.oup.com
Primary central nervous system lymphoma (PCNSL) is a rare form of non-Hodgkin
lymphoma that affects the brain parenchyma, spinal cord, eyes, and cerebrospinal fluid …

Detection, characterization, and inhibition of FGFR–TACC fusions in IDH wild-type glioma

AL Di Stefano, A Fucci, V Frattini, M Labussiere… - Clinical cancer …, 2015 - AACR
Purpose: Oncogenic fusions consisting of fibroblast growth factor receptor (FGFR) and
TACC are present in a subgroup of glioblastoma (GBM) and other human cancers and have …